InsidersTradesSigma
Oscar Health, Inc. Stock: price and insider trades · United States · SEC (Form 4)
Track the Oscar Health, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Oscar Health, Inc. has recorded 214 public disclosures. Market capitalisation: €9.7bn. The latest transaction was reported on 1 July 2026 (Cession). Among the most active insiders: Blackley Richard Scott. All data is openly available.
214
Insider Decl.
0
Thresholds
€107m
37 ops.
Buy Volume
€46m
31 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Oscar Health, Inc. Hold (neutral), based on 10 analysts. Average price target: US$22.60.
40Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,279 of 25,535 companies
34.3
score / 100
Value52
Quality16
FCF yld11%
Earn yld-4.7%
EV/EBITDA·
ROE-2.6%
Gross mgn·
Net mgn-3.8%
Debt/EBITDA10.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 July 2026
Declarations214 total
555,826 sharesClass A Common StockSEC:0001568651-26-000060:0
58,926 sharesClass A Common StockSEC:0001568651-26-000060:1
488,654 sharesClass A Common StockSEC:0001568651-26-000060:2
135,590 sharesClass A Common StockSEC:0001568651-26-000060:3
597,942 sharesClass A Common StockSEC:0001352552-26-000010:0
17,200 sharesClass A Common StockSEC:0001352552-26-000010:1
441,373 sharesClass A Common StockSEC:0001352552-26-000010:2
149,795 sharesClass A Common StockSEC:0001352552-26-000010:3
880,000 sharesClass A Common StockSEC:0001844320-26-000011:0
286,988 sharesClass A Common StockSEC:0001844320-26-000011:1
591,213 sharesClass A Common StockSEC:0001844320-26-000011:2
1,799 sharesClass A Common StockSEC:0001844320-26-000011:3
50,000 sharesClass A Common StockSEC:0001844320-26-000011:4
16,307 sharesClass A Common StockSEC:0001844320-26-000011:5
33,591 sharesClass A Common StockSEC:0001844320-26-000011:6
102 sharesClass A Common StockSEC:0001844320-26-000011:7
50,000 sharesClass A Common StockSEC:0001844320-26-000011:8
16,306 sharesClass A Common StockSEC:0001844320-26-000011:9
33,592 sharesClass A Common StockSEC:0001844320-26-000011:10
102 sharesClass A Common StockSEC:0001844320-26-000011:11
47,500 sharesClass A Common StockSEC:0001844320-26-000011:12
15,491 sharesClass A Common StockSEC:0001844320-26-000011:13
31,912 sharesClass A Common StockSEC:0001844320-26-000011:14
97 sharesClass A Common StockSEC:0001844320-26-000011:15
1,091 shares@ US$21.740.0002% mcap12.8% of flowClass A Common StockSEC:0001911946-26-000004:0
25 of 214 declarations
About Oscar Health, Inc.
Oscar Health, Inc. (NYSE: OSCR) is a U.S.-listed healthcare company headquartered in New York City, United States. Founded in 2012, Oscar was built as a technology-driven health insurer with a clear consumer focus: simplify access to care, improve the member experience, and use software and data to make insurance easier to navigate. For francophone investors, Oscar stands out less as a classic incumbent insurer and more as a digital-first healthcare platform wrapped around regulated insurance products. Oscar’s core business is health insurance, with a particular emphasis on the ACA individual marketplace. The company also serves families, small groups, and, since 2020, Medicare Advantage members. Its product mix is anchored in medical coverage sold to consumers and employers, while its technology stack supports enrollment, customer service, care navigation, and increasingly AI-enabled tools. Oscar also positions its platform as an asset in itself, suggesting a broader ambition to leverage its operating capabilities beyond policy administration. Competitive positioning is central to the investment case. Oscar operates in a large but highly regulated U.S. insurance market where scale, pricing discipline, medical cost management, and compliance matter as much as brand and digital experience. The company competes against major national carriers and more specialized ACA-focused insurers. Its differentiators are a user-friendly digital experience, a member-centric brand, and a technology-led operating model. At the same time, Oscar remains exposed to the typical insurance variables: claims volatility, risk adjustment dynamics, regulatory changes, and the economics of the individual marketplace. Recent developments have been constructive on the commercial side. Oscar said it ended 2025 with a record membership base of roughly 3.4 million and entered 2026 with a sharper focus on profitability and margin expansion. In the first quarter of 2026, the company reported approximately $4.6 billion of revenue and reaffirmed its 2026 guidance. Oscar has also launched new affordable health-plan choices and AI features tied to the 2026 open enrollment cycle, while expanding into multiple U.S. markets including New Jersey, Southern Florida, Mississippi, Charlotte, and Dayton. For investors, this suggests a company that is still growth-oriented, but increasingly focused on disciplined execution and profitability. As a NYSE-listed name in the United States, Oscar combines the attributes of a regulated insurer with the optionality of a health-tech platform.
